Description
Indications
Indicated for adults with primary biliary cholangitis who have an inadequate response to ursodeoxycholic acid or cannot tolerate it.
Mécanisme d’action
Elafibranor Mecanisme d action Mecanisme d action ,
Posologie
2 , , / (2.1) 80 mg, (2.2) 2.1 IQIRVO IQIRVO [ Precautions (5.1)] IQIRVO , [ Precautions (5.3), (8.1, 8.3)] 2.2 IQIRVO 80 mg, [ (12.3)] 2.3 IQIRVO 4 4 , [ (7.2)]
Precautions
5 Precautions IQIRVO , (CPK) , IQIRVO 5.1 IQIRVO , 5.2

